Health ❯ Healthcare ❯ Drug Safety
Clinical Trials Cancer Risks Treatment-Related Adverse Effects Clinical Study Results FDA Warnings Patient Safety Anemia Vision Loss Mifepristone Complications Osimertinib Liver Injury Ocular Toxicity Cardiovascular Risks Osimertinib Toxicity Clinical Outcomes Eye Health Cancer Malignancies Gastrointestinal Symptoms Biomarkers Clinical Guidelines Guillain-Barré Syndrome Tolerability Studies Treatment Tolerability Treatment-Related AEs Trial Outcomes Pertuzumab-dpzb Adverse Effects Chemotherapy Risks Warnings and Precautions Neurological Problems Tramadol Side Effects Medication Tolerance Tolerability
Want to see what podcasts are saying about this topic? Search across 125K+ podcasts. Explore Radar
The committee found the pivotal ADVOCATE trial breached good clinical practice and persistent reports of serious liver injury mean the drug’s benefits can no longer be shown to outweigh its risks.
